Found 0 matching trials
Azacytidine, Bendamustine, Piamprizumab in Refractory/Relapsed B-cell Non-Hodgkin's Lymphoma PHASE1 This is an open label, single arm, phase I/II for patients with r/r Non-Hod...
Show More Location
Biotherapeutic Department of Chinese PLA General Hospital
Learn More & Join Trial
A Clinical Trial to Evaluate the Efficacy and Safety of TQB3909 Tablets Versus Investigator's Choice in the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) PHASE3 To Evaluate the Efficacy and Safety of TQB3909 Tablets versus Investigator'...
Show More Learn More & Join Trial
Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma PHASE1 This research study combines 2 different ways of fighting disease: antibodi...
Show More Status
Active Not Recruiting
Location
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Learn More & Join Trial
Safety and Efficacy Study of Bendamustine to Treat Non-Hodgkin Lymphoma PHASE3 The purpose of this study is to determine whether bendamustine HCl for inje...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
Bendamustine Hydrochloride Injection for Initial Treatment of Chronic Lymphocytic Leukemia PHASE2 To compare the clinical efficacy and safety of bendamustine hydrochloride v...
Show More Location
Ruijin Hospital Affiliated to Shanghai JiaoTong University School of Medicine
Learn More & Join Trial
Phase I/II Study of SyB L-0501RI in Combination With Rituximab to Treat Lymphoma PHASE1 For SyB L-0501RI administered by an intravenous rapid infusion in combinati...
Show More Learn More & Join Trial